For Theranos I guess it was roughly: 1) list of big names advising or on board of directors acquired through connections 2) total adressable market of blood t

For Theranos I guess it was roughly: 1) list of big names advising or on board of directors acquired through connections 2) total adressable market of blood tests 3) current cost and complexity - need full vial for each single test 4) promise of lower cost and complexity - just one drop of blood 5) at some point down the time line they likely have added DoD contract and Walgreens partnership